The osteoblast to osteocyte transition: Epigenetic changes and response to the vitamin D3 hormone

Hillary C. St. John, Kathleen A. Bishop, Mark B. Meyer, Nancy A. Benkusky, Ning Leng, Christina Kendziorski, Lynda Bonewald, J. Wesley Pike

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Osteocytes are derived from osteoblast lineage cells that become progressively embedded in mineralized bone. Development of the osteocytogenic cell line IDG-SW3 has enabled a temporal and mechanistic investigation of this process. Through RNA-sequencing analyses, we show that although substantial changes in gene expression occur during the osteoblast to osteocyte transition, the majority of the transcriptome remains qualitatively osteoblast like. Genes either upregulated or expressed uniquely in the osteocyte include local and systemic factors such as Sost and Fgf23 as well as genes implicated in neuronal, muscle, vascular, or regulatory function. As assessed by chromatin immunoprecipitation coupled to high-throughput sequencing, numerous changes in epigenetic histone modifications also occur during osteocytogenesis; these are largely qualitative rather than quantitative. Specific epigenetic changes correlate with altered gene expression patterns that are observed during the transition. These genomic changes likely influence the highly restricted transcriptomic response to 1,25(OH)2D3 that occurs during differentiation. VDR binding in osteocytes revealed an extensive cistrome co-occupied by retinoid X receptor and located predominantly at sites distal to regulated genes. Although sites of VDR binding were apparent near many 1,25(OH)2D3regulated genes, the expression of others adjacent to VDRbinding sites were unaffected; lack of VDR binding was particularly prevalent at down-regulated genes. Interestingly, 1,25(OH)2D3 was found to induce the Boc and Cdon coreceptors that are active in hedgehog signaling in osteocytes. We conclude that osteocytogenesis is accompanied by changes in gene expression that may be driven by both genetic and epigenetic components. These changes are likely responsible for the osteocyte phenotype and may contribute to reduced sensitivity to 1,25(OH)2D3.

Original languageEnglish (US)
Pages (from-to)1150-1165
Number of pages16
JournalMolecular Endocrinology
Volume28
Issue number7
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Osteocytes
Cholecalciferol
Osteoblasts
Epigenomics
Hormones
Gene Expression
Genes
Histone Code
RNA Sequence Analysis
Retinoid X Receptors
Chromatin Immunoprecipitation
Transcriptome
Blood Vessels
Binding Sites
Phenotype
Bone and Bones
Cell Line
Muscles

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology
  • Medicine(all)

Cite this

St. John, H. C., Bishop, K. A., Meyer, M. B., Benkusky, N. A., Leng, N., Kendziorski, C., ... Wesley Pike, J. (2014). The osteoblast to osteocyte transition: Epigenetic changes and response to the vitamin D3 hormone. Molecular Endocrinology, 28(7), 1150-1165. https://doi.org/10.1210/me.2014-1091

The osteoblast to osteocyte transition : Epigenetic changes and response to the vitamin D3 hormone. / St. John, Hillary C.; Bishop, Kathleen A.; Meyer, Mark B.; Benkusky, Nancy A.; Leng, Ning; Kendziorski, Christina; Bonewald, Lynda; Wesley Pike, J.

In: Molecular Endocrinology, Vol. 28, No. 7, 2014, p. 1150-1165.

Research output: Contribution to journalArticle

St. John, HC, Bishop, KA, Meyer, MB, Benkusky, NA, Leng, N, Kendziorski, C, Bonewald, L & Wesley Pike, J 2014, 'The osteoblast to osteocyte transition: Epigenetic changes and response to the vitamin D3 hormone', Molecular Endocrinology, vol. 28, no. 7, pp. 1150-1165. https://doi.org/10.1210/me.2014-1091
St. John, Hillary C. ; Bishop, Kathleen A. ; Meyer, Mark B. ; Benkusky, Nancy A. ; Leng, Ning ; Kendziorski, Christina ; Bonewald, Lynda ; Wesley Pike, J. / The osteoblast to osteocyte transition : Epigenetic changes and response to the vitamin D3 hormone. In: Molecular Endocrinology. 2014 ; Vol. 28, No. 7. pp. 1150-1165.
@article{72f93211cf8444199e71967179ebbd7d,
title = "The osteoblast to osteocyte transition: Epigenetic changes and response to the vitamin D3 hormone",
abstract = "Osteocytes are derived from osteoblast lineage cells that become progressively embedded in mineralized bone. Development of the osteocytogenic cell line IDG-SW3 has enabled a temporal and mechanistic investigation of this process. Through RNA-sequencing analyses, we show that although substantial changes in gene expression occur during the osteoblast to osteocyte transition, the majority of the transcriptome remains qualitatively osteoblast like. Genes either upregulated or expressed uniquely in the osteocyte include local and systemic factors such as Sost and Fgf23 as well as genes implicated in neuronal, muscle, vascular, or regulatory function. As assessed by chromatin immunoprecipitation coupled to high-throughput sequencing, numerous changes in epigenetic histone modifications also occur during osteocytogenesis; these are largely qualitative rather than quantitative. Specific epigenetic changes correlate with altered gene expression patterns that are observed during the transition. These genomic changes likely influence the highly restricted transcriptomic response to 1,25(OH)2D3 that occurs during differentiation. VDR binding in osteocytes revealed an extensive cistrome co-occupied by retinoid X receptor and located predominantly at sites distal to regulated genes. Although sites of VDR binding were apparent near many 1,25(OH)2D3regulated genes, the expression of others adjacent to VDRbinding sites were unaffected; lack of VDR binding was particularly prevalent at down-regulated genes. Interestingly, 1,25(OH)2D3 was found to induce the Boc and Cdon coreceptors that are active in hedgehog signaling in osteocytes. We conclude that osteocytogenesis is accompanied by changes in gene expression that may be driven by both genetic and epigenetic components. These changes are likely responsible for the osteocyte phenotype and may contribute to reduced sensitivity to 1,25(OH)2D3.",
author = "{St. John}, {Hillary C.} and Bishop, {Kathleen A.} and Meyer, {Mark B.} and Benkusky, {Nancy A.} and Ning Leng and Christina Kendziorski and Lynda Bonewald and {Wesley Pike}, J.",
year = "2014",
doi = "10.1210/me.2014-1091",
language = "English (US)",
volume = "28",
pages = "1150--1165",
journal = "Molecular Endocrinology",
issn = "0888-8809",
publisher = "The Endocrine Society",
number = "7",

}

TY - JOUR

T1 - The osteoblast to osteocyte transition

T2 - Epigenetic changes and response to the vitamin D3 hormone

AU - St. John, Hillary C.

AU - Bishop, Kathleen A.

AU - Meyer, Mark B.

AU - Benkusky, Nancy A.

AU - Leng, Ning

AU - Kendziorski, Christina

AU - Bonewald, Lynda

AU - Wesley Pike, J.

PY - 2014

Y1 - 2014

N2 - Osteocytes are derived from osteoblast lineage cells that become progressively embedded in mineralized bone. Development of the osteocytogenic cell line IDG-SW3 has enabled a temporal and mechanistic investigation of this process. Through RNA-sequencing analyses, we show that although substantial changes in gene expression occur during the osteoblast to osteocyte transition, the majority of the transcriptome remains qualitatively osteoblast like. Genes either upregulated or expressed uniquely in the osteocyte include local and systemic factors such as Sost and Fgf23 as well as genes implicated in neuronal, muscle, vascular, or regulatory function. As assessed by chromatin immunoprecipitation coupled to high-throughput sequencing, numerous changes in epigenetic histone modifications also occur during osteocytogenesis; these are largely qualitative rather than quantitative. Specific epigenetic changes correlate with altered gene expression patterns that are observed during the transition. These genomic changes likely influence the highly restricted transcriptomic response to 1,25(OH)2D3 that occurs during differentiation. VDR binding in osteocytes revealed an extensive cistrome co-occupied by retinoid X receptor and located predominantly at sites distal to regulated genes. Although sites of VDR binding were apparent near many 1,25(OH)2D3regulated genes, the expression of others adjacent to VDRbinding sites were unaffected; lack of VDR binding was particularly prevalent at down-regulated genes. Interestingly, 1,25(OH)2D3 was found to induce the Boc and Cdon coreceptors that are active in hedgehog signaling in osteocytes. We conclude that osteocytogenesis is accompanied by changes in gene expression that may be driven by both genetic and epigenetic components. These changes are likely responsible for the osteocyte phenotype and may contribute to reduced sensitivity to 1,25(OH)2D3.

AB - Osteocytes are derived from osteoblast lineage cells that become progressively embedded in mineralized bone. Development of the osteocytogenic cell line IDG-SW3 has enabled a temporal and mechanistic investigation of this process. Through RNA-sequencing analyses, we show that although substantial changes in gene expression occur during the osteoblast to osteocyte transition, the majority of the transcriptome remains qualitatively osteoblast like. Genes either upregulated or expressed uniquely in the osteocyte include local and systemic factors such as Sost and Fgf23 as well as genes implicated in neuronal, muscle, vascular, or regulatory function. As assessed by chromatin immunoprecipitation coupled to high-throughput sequencing, numerous changes in epigenetic histone modifications also occur during osteocytogenesis; these are largely qualitative rather than quantitative. Specific epigenetic changes correlate with altered gene expression patterns that are observed during the transition. These genomic changes likely influence the highly restricted transcriptomic response to 1,25(OH)2D3 that occurs during differentiation. VDR binding in osteocytes revealed an extensive cistrome co-occupied by retinoid X receptor and located predominantly at sites distal to regulated genes. Although sites of VDR binding were apparent near many 1,25(OH)2D3regulated genes, the expression of others adjacent to VDRbinding sites were unaffected; lack of VDR binding was particularly prevalent at down-regulated genes. Interestingly, 1,25(OH)2D3 was found to induce the Boc and Cdon coreceptors that are active in hedgehog signaling in osteocytes. We conclude that osteocytogenesis is accompanied by changes in gene expression that may be driven by both genetic and epigenetic components. These changes are likely responsible for the osteocyte phenotype and may contribute to reduced sensitivity to 1,25(OH)2D3.

UR - http://www.scopus.com/inward/record.url?scp=84903624784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903624784&partnerID=8YFLogxK

U2 - 10.1210/me.2014-1091

DO - 10.1210/me.2014-1091

M3 - Article

C2 - 24877565

AN - SCOPUS:84903624784

VL - 28

SP - 1150

EP - 1165

JO - Molecular Endocrinology

JF - Molecular Endocrinology

SN - 0888-8809

IS - 7

ER -